NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone

Back to Agenda

Session 4 : Korea’s Strategy for going Global

VP, Clinical & Regulatory Affairs Center

LG Chem, Korea, Republic of

SK biopharmaceuticals, Korea, Republic of

YULCHON LLC, Korea, Republic of

Patent Attorney

Bridge Biotherapeutics Inc., Korea, Republic of

Vice President, Clinical Development Strategy

Have an account?